QIAGEN Receives European IVDR Certification For QIAstat-Dx Syndromic Testing Instruments And Assays
Looking Into Alnylam Pharmaceuticals's Recent Short Interest
QIAGEN And BD Joint Venture, PreAnalytiX, Launches Solution For Liquid Biopsy From Urine Samples
Goldman Sachs Bullish On Avidity Biosciences, Cites Scalable RNA Therapeutics Platform For Rare Diseases
Pfizer Canada And BioNTech Receive Health Canada Approval Of Omicron KP.2 Variant Adapted COVID-19 Vaccine
Exxon Mobil To $120? Here Are 10 Top Analyst Forecasts For Tuesday
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
Pfizer/BioNTech New COVID Shot Endorsed by EMA Advisory Panel
Watching BioNTech; Traders Circulating Stock Picked By Popular Retail Trading Newsletter
Analyst Expectations For Myriad Genetics's Future
Myriad Genetics Analyst Ratings
QIAGEN Expands QIAcuity Digital PCR Offering With Over 100 New Assays Via GeneGlobe Platform, Supporting Cancer Research, Genetic Disorders, Infectious Disease Surveillance, And Environmental Monitoring
10 Health Care Stocks With Whale Alerts In Today's Session
UBS Maintains Neutral on BioNTech, Raises Price Target to $131
Unveiling 7 Analyst Insights On Avidity Biosciences
Cantor Fitzgerald Reiterates Overweight on Avidity Biosciences, Maintains $96 Price Target
Avidity Biosciences Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Ultragenyx Pharmaceutical, Maintains $116 Price Target
Ultragenyx Pharmaceutical Analyst Ratings
DeSantis Administration Cautions Against Pfizer, Moderna MRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions